Overlap between non-steroidal anti-inflammatory drugs (NSAIDs) and anti-rheumatoid drugs (ARDs).
Dixon
J S
JS
D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001310:Auranofin; D006051:Aurothioglucose / Q000031:analogs & derivatives / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D019804:Mesalamine; D008667:Metalloproteins / Q000627:therapeutic use; D010396:Penicillamine / Q000627:therapeutic use; D010648:Phenylacetates / Q000627:therapeutic use; D010894:Piroxicam / Q000031:analogs & derivatives*; D011422:Propionates / Q000627:therapeutic use; D013843:Thiazines / Q000627:therapeutic use
D000636:Aminosalicylic Acids; D000893:Anti-Inflammatory Agents; D008667:Metalloproteins; D010648:Phenylacetates; D011422:Propionates; D013843:Thiazines; D010894:Piroxicam; C011677:benoxaprofen; D006051:Aurothioglucose; D001310:Auranofin; D019804:Mesalamine; D006046:Gold; C013580:isoxicam; D010396:Penicillamine; C005180:orgotein; C012970:fenclofenac